pyrazines has been researched along with pk 11195 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, KC; Chauhan, D; Cotter, FE; Hideshima, T; Li, G; Mitsiades, C; Munshi, N; Podar, K; Richardson, P; Schlossman, R | 1 |
Deeva, OA; Gudasheva, TA; Mokrov, GV; Seredenin, SB; Yarkov, SA; Yarkova, MA | 1 |
2 other study(ies) available for pyrazines and pk 11195
Article | Year |
---|---|
Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.
Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Caspases; Cell Survival; Cytochromes c; Drug Resistance, Neoplasm; Drug Synergism; GABA-A Receptor Antagonists; Humans; Insulin-Like Growth Factor I; Interleukin-6; Isoquinolines; JNK Mitogen-Activated Protein Kinases; Lymphocytes; Membrane Potentials; Mitochondria; Multiple Myeloma; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Stromal Cells; Superoxides; Tumor Cells, Cultured | 2004 |
Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides.
Topics: Amides; Animals; Anti-Anxiety Agents; Anxiety; Binding Sites; Diazepam; Dose-Response Relationship, Drug; Drug Design; Gene Expression; Isoquinolines; Ligands; Male; Maze Learning; Mice; Mice, Inbred BALB C; Motor Activity; Protein Binding; Pyrazines; Receptors, GABA; Structure-Activity Relationship | 2015 |